3D Printed Kidney Tumors Could Transform Renal Cancer Research

Researchers at Tsinghua University recently announced that they have developed a new use for 3D printing that could potentially change how doctors study and treat forms of kidney cancer. The research team developed a way to bioprint kidney tumors directly from a patient’s cells. This creates a hyperrealistic model that replicates the complex environment of tumors from inside the body.

Their work was recently published in the ‘Biofabrication’ journal, where they demonstrate the process and how bioprinting can combine tumor cells with supportive cell types. Additionally, the bioprinting can create structures similar to blood vessels. These printed tumors, referred to as organoids, reproduce the exact characteristics of a patient’s cancer. This provides a far more accurate tool for research and treatment testing than conventional lab models.

Kidney cancer, specifically renal cell carcinoma (RCC), has been on the rise recently. Treatment remains difficult because patients typically respond differently to chemotherapy and targeted drugs. Tumors often tend to mutate over time, leading to drug resistance and a higher risk of recurrence. Traditional laboratory models often fall short because they do not fully capture how tumors grow and react inside the human body. This often makes it harder to identify effective therapies.